Suppr超能文献

在小鼠肠道内口服杆菌肽期间以及体外生长期间革兰氏阴性菌释放内毒素的动力学

Kinetics of endotoxin release by gram-negative bacteria in the intestinal tract of mice during oral administration of bacitracin and during in vitro growth.

作者信息

Goris H, de Boer F, van der Waaij D

机构信息

Laboratory for Medical Microbiology, State University, Groningen, The Netherlands.

出版信息

Scand J Infect Dis. 1988;20(2):213-9. doi: 10.3109/00365548809032440.

Abstract

The release of endotoxin by gram-negative bacteria was studied during bacitracin-induced intestinal colonization in C3H/Law mice and during in vitro growth. The "free" endotoxin concentration was determined by the Limulus amebocyte lysate test in faecal and in culture supernatants, respectively. After oral administration of bacitracin for 2 days a significant (p less than 0.001) increase of the faecal concentration of gram-negative bacteria of 3-4 logs accompanied a significant (p less than 0.001) increase of the faecal endotoxin concentration from 10(1.8 +/- 0.2) to 10(3.3 +/- 0.2) micrograms endotoxin/g faeces. In vitro, however, an increase of the concentration of gram-negative bacteria of 3-4 logs resulted in a 3-4 log increase of the concentration of endotoxin during the exponential and early stationary growth phase. The faecal endotoxin level after 8 days of bacitracin treatment dropped to a value not significantly different from the initial value, regardless of a high faecal level of gram-negative bacteria. Endotoxin determination by the Limulus amebocyte lysate test appeared to be unaffected by the amount of bacitracin present in faecal preparations after oral administration of this antibiotic. In addition, the in vitro release of endotoxin was not influenced by bacitracin. From these results we conclude, that "free" endotoxin is a product of extensive proliferation of gram-negative bacteria. Therefore, the intestinal endotoxin level does not necessarily correlate with the level of gram-negative bacteria, but corresponds with the proliferative activity of these bacteria.

摘要

在杆菌肽诱导C3H/Law小鼠肠道定植期间以及体外生长过程中,对革兰氏阴性菌释放内毒素的情况进行了研究。分别通过鲎试剂法测定粪便和培养上清液中的“游离”内毒素浓度。口服杆菌肽2天后,革兰氏阴性菌粪便浓度显著(p<0.001)增加3 - 4个对数,同时粪便内毒素浓度也显著(p<0.001)增加,从10(1.8±0.2)微克内毒素/克粪便增至10(3.3±0.2)微克内毒素/克粪便。然而在体外,在指数生长期和早期稳定生长期,革兰氏阴性菌浓度增加3 - 4个对数会导致内毒素浓度增加3 - 4个对数。杆菌肽治疗8天后,粪便内毒素水平降至与初始值无显著差异的值,尽管粪便中革兰氏阴性菌水平较高。口服这种抗生素后,通过鲎试剂法测定内毒素似乎不受粪便制剂中杆菌肽含量的影响。此外,体外内毒素释放不受杆菌肽影响。从这些结果我们得出结论,“游离”内毒素是革兰氏阴性菌大量增殖的产物。因此,肠道内毒素水平不一定与革兰氏阴性菌水平相关,而是与这些细菌的增殖活性相对应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验